Figure 2.

Histopathological demonstration of the myeloid expansion in chronic phase CML (upper panels), resulting in the advanced blastic crisis of CML (lower panels) with failure of tyrosine kinase inhibitors (courtesy of Professor Ayşegül Üner, MD, from Hacettepe University Medical School, Ankara, Turkey).